These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 34947886)

  • 1. Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy.
    Fasano R; Shadbad MA; Brunetti O; Argentiero A; Calabrese A; Nardulli P; Calbi R; Baradaran B; Silvestris N
    Life (Basel); 2021 Dec; 11(12):. PubMed ID: 34947886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma.
    Shen W; Chen Y; Lei P; Sheldon M; Sun Y; Yao F; Ma L
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment.
    Leone P; Solimando AG; Fasano R; Argentiero A; Malerba E; Buonavoglia A; Lupo LG; De Re V; Silvestris N; Racanelli V
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34065489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    J Exp Clin Cancer Res; 2019 Sep; 38(1):396. PubMed ID: 31500650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.
    Oura K; Morishita A; Tani J; Masaki T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future.
    Minaei N; Ramezankhani R; Tamimi A; Piryaei A; Zarrabi A; Aref AR; Mostafavi E; Vosough M
    Eur J Cell Biol; 2023 Mar; 102(1):151284. PubMed ID: 36584598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma.
    Zhao M; Huang H; He F; Fu X
    Front Immunol; 2023; 14():1188277. PubMed ID: 37275909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma.
    Tian BW; Han CL; Dong ZR; Tan SY; Wang DX; Li T
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The State of Immunotherapy in Hepatobiliary Cancers.
    Ilyas FZ; Beane JD; Pawlik TM
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for Hepatocellular Carcinoma: A 2021 Update.
    Kole C; Charalampakis N; Tsakatikas S; Vailas M; Moris D; Gkotsis E; Kykalos S; Karamouzis MV; Schizas D
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33020428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and Treatment of Hepatocellular Carcinoma with Immunotherapy: A Review of Current and Future Options.
    Ghavimi S; Apfel T; Azimi H; Persaud A; Pyrsopoulos NT
    J Clin Transl Hepatol; 2020 Jun; 8(2):168-176. PubMed ID: 32832397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of hepatocellular carcinoma: recent progress and new strategy.
    Li J; Xuan S; Dong P; Xiang Z; Gao C; Li M; Huang L; Wu J
    Front Immunol; 2023; 14():1192506. PubMed ID: 37234162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future.
    Wei H; Dong C; Li X
    J Clin Transl Hepatol; 2024 Apr; 12(4):389-405. PubMed ID: 38638377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
    Russell L; Peng KW; Russell SJ; Diaz RM
    BioDrugs; 2019 Oct; 33(5):485-501. PubMed ID: 31321623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis.
    Ding Z; Dong Z; Chen Z; Hong J; Yan L; Li H; Yao S; Yan Y; Yang Y; Yang C; Li T
    Front Immunol; 2021; 12():733530. PubMed ID: 34659220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Immunotherapy in Hepatocellular Carcinoma.
    Miao L; Zhang Z; Ren Z; Li Y
    Front Oncol; 2021; 11():699060. PubMed ID: 34513678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies and challenges of immunotherapy for hepatocellular carcinoma].
    Zhang HH; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):457-460. PubMed ID: 32660170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocytes in hepatocellular carcinoma immune microenvironment: insights into human immunology and immunotherapy.
    Bian J; Lin J; Long J; Yang X; Yang X; Lu X; Sang X; Zhao H
    Am J Cancer Res; 2020; 10(12):4585-4606. PubMed ID: 33415021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade.
    Wang X; Yang T; Shi X
    Cell Signal; 2024 Dec; 124():111405. PubMed ID: 39260532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunology of Hepatocellular Carcinoma.
    Lawal G; Xiao Y; Rahnemai-Azar AA; Tsilimigras DI; Kuang M; Bakopoulos A; Pawlik TM
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.